“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Is It Seditious to Oppose Drone-Killing? If So, Count me as a Seditionist
Should Cops Enforce Internet Etiquette?
"Six strikes" Internet warning system will come to US this year
Semi-Automatic Rifle Reporting Mandated in (Mexican) Border States
Did Obama Violate Copyright Law Watching the Super Bowl?
Pensco Allows Self-Directed IRA Investors To Invest In Bitcoin
CA Medical Marijuana Dispensary Numbers Shrink in Two-Pronged War of Attrition
Cuba part three, Cuban-U.S. relations: end the embargo now
Not a Peep from Obama: Violent Crime Now at a 42-Year Low
Jesse Trentadue: Death, Lies, and Revenge in Federal Custody
In phishing attack, Microsoft’s unmentionables aired by hacktivists
The Single Most Important Strategy Most Investors Ignore
TeenSafe phone monitoring app leaks teens’ iCloud logins in plaintext
Next Stop On The Road To Surveillance State: License Plate Scanners
“Zero Tolerance” — Mass Trials and Children Taken From Their Parents